Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C.

Zeerleder S, Stephan F, Emonts M, de Kleijn ED, Esmon CT, Varadi K, Hack CE, Hazelzet JA.

Crit Care Med. 2012 Dec;40(12):3224-9. doi: 10.1097/CCM.0b013e318265695f.

PMID:
22932399
2.
3.

Serum lipids and disease severity in children with severe meningococcal sepsis.

Vermont CL, den Brinker M, Kâkeci N, de Kleijn ED, de Rijke YB, Joosten KF, de Groot R, Hazelzet JA.

Crit Care Med. 2005 Jul;33(7):1610-5.

PMID:
16003070
4.

Gut mucosal cell damage in meningococcal sepsis in children: relation with clinical outcome.

Derikx JP, Bijker EM, Vos GD, van Bijnen AA, Heineman E, Buurman WA, van Waardenburg DA.

Crit Care Med. 2010 Jan;38(1):133-7. doi: 10.1097/CCM.0b013e3181b4a5ed.

PMID:
19730255
5.

Circulating nucleosomes as a predictor of sepsis and organ dysfunction in critically ill patients.

Chen Q, Ye L, Jin Y, Zhang N, Lou T, Qiu Z, Jin Y, Cheng B, Fang X.

Int J Infect Dis. 2012 Jul;16(7):e558-64. doi: 10.1016/j.ijid.2012.03.007. Epub 2012 May 18.

6.

Elevated nucleosome levels in systemic inflammation and sepsis.

Zeerleder S, Zwart B, Wuillemin WA, Aarden LA, Groeneveld AB, Caliezi C, van Nieuwenhuijze AE, van Mierlo GJ, Eerenberg AJ, Lämmle B, Hack CE.

Crit Care Med. 2003 Jul;31(7):1947-51.

PMID:
12847387
7.

CC and CXC chemokine levels in children with meningococcal sepsis accurately predict mortality and disease severity.

Vermont CL, Hazelzet JA, de Kleijn ED, van den Dobbelsteen GP, de Groot R.

Crit Care. 2006 Feb;10(1):R33.

8.

Treatment of purpura fulminans in meningococcemia with protein C concentrate.

Rivard GE, David M, Farrell C, Schwarz HP.

J Pediatr. 1995 Apr;126(4):646-52.

PMID:
7699550
9.

Replacement therapy with protein C concentrate in infants and adolescents with meningococcal sepsis and purpura fulminans.

Ettingshausen CE, Veldmann A, Beeg T, Schneider W, Jäger G, Kreuz W.

Semin Thromb Hemost. 1999;25(6):537-41.

PMID:
10632475
10.

Activation of factor VII-activating protease in human inflammation: a sensor for cell death.

Stephan F, Hazelzet JA, Bulder I, Boermeester MA, van Till JO, van der Poll T, Wuillemin WA, Aarden LA, Zeerleder S.

Crit Care. 2011;15(2):R110. doi: 10.1186/cc10131. Epub 2011 Apr 5.

11.
12.

Recombinant bactericidal/permeability-increasing protein (rBPI21) as adjunctive treatment for children with severe meningococcal sepsis: a randomised trial. rBPI21 Meningococcal Sepsis Study Group.

Levin M, Quint PA, Goldstein B, Barton P, Bradley JS, Shemie SD, Yeh T, Kim SS, Cafaro DP, Scannon PJ, Giroir BP.

Lancet. 2000 Sep 16;356(9234):961-7.

PMID:
11041396
13.

[Replacement therapy with protein C for meningococcal sepsis and fulminant purpura in pediatric patients].

Llinares Tello F, Hernández Prats C, Burgos San José A, Bosacoma Ros N, Alcalá Minagorre P, López Rodríguez F, Reig Sáenz R, Marco Vera P, Ordovás Baines JP.

Farm Hosp. 2004 Mar-Apr;28(2):130-6. Spanish.

14.

Selenium in Intensive Care (SIC): results of a prospective randomized, placebo-controlled, multiple-center study in patients with severe systemic inflammatory response syndrome, sepsis, and septic shock.

Angstwurm MW, Engelmann L, Zimmermann T, Lehmann C, Spes CH, Abel P, Strauss R, Meier-Hellmann A, Insel R, Radke J, Schüttler J, Gärtner R.

Crit Care Med. 2007 Jan;35(1):118-26.

PMID:
17095947
15.

Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study.

Verhoeven JJ, den Brinker M, Hokken-Koelega AC, Hazelzet JA, Joosten KF.

Crit Care. 2011;15(1):R44. doi: 10.1186/cc10006. Epub 2011 Jan 31.

16.

[Protein C concentrate in the treatment of severe sepsis in the pediatric setting].

Ramos Guerrero R, López Castilla JD, Atienza Fernández M, Bautista Paloma J, Ramos Guerrero AJ, Muñoz Sáez M, Carranza Conde M, Soult Rubio JA.

Farm Hosp. 2003 Nov-Dec;27(6):391-5. Spanish.

17.

Clinical course of sepsis in children with acute leukemia admitted to the pediatric intensive care unit.

Singer K, Subbaiah P, Hutchinson R, Odetola F, Shanley TP.

Pediatr Crit Care Med. 2011 Nov;12(6):649-54. doi: 10.1097/PCC.0b013e31821927f1.

PMID:
21478790
18.

Antioxidant protection against iron in children with meningococcal sepsis.

Festa M, Mumby S, Nadel S, Gutteridge JM, Quinlan GJ.

Crit Care Med. 2002 Jul;30(7):1623-9.

PMID:
12130989
19.

One single dose of etomidate negatively influences adrenocortical performance for at least 24h in children with meningococcal sepsis.

den Brinker M, Hokken-Koelega AC, Hazelzet JA, de Jong FH, Hop WC, Joosten KF.

Intensive Care Med. 2008 Jan;34(1):163-8. Epub 2007 Aug 21.

20.

Protein C replacement in severe meningococcemia: rationale and clinical experience.

Alberio L, Lämmle B, Esmon CT.

Clin Infect Dis. 2001 May 1;32(9):1338-46. Epub 2001 Apr 9. Review. Erratum in: Clin Infect Dis 2001 Jun 15;32(12):1803.

PMID:
11303270

Supplemental Content

Support Center